Search

Your search keyword '"Merck Sharp & Dohme Corp. -- Intellectual property"' showing total 36 results
Start Over Descriptor "Merck Sharp & Dohme Corp. -- Intellectual property" Search Limiters Available in Library Collection
36 results on '"Merck Sharp & Dohme Corp. -- Intellectual property"'

1. 'Combination Of A Pd-1 Antagonist And A Vegfr/Fgfr/Ret Tyrosine Kinase Inhibitor For Treating Cancer' in Patent Application Approval Process (USPTO 20220023285)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Women -- Health aspects, Tyrosine -- Intellectual property, Phenols -- Intellectual property, Cancer -- Care and treatment, Palladium -- Intellectual property, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 FEB 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DENKER, Andrew Evan (North Wales, PA, US); HORI, [...]

Published
2022

2. Patent Issued for Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for treating cancer (USPTO 11147806)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Endothelial growth factors -- Reports, Women -- Health aspects, Tyrosine -- Intellectual property -- Reports, Phenols -- Intellectual property -- Reports, Cancer -- Care and treatment -- Reports, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 NOV 11 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Denker, Andrew [...]

Published
2021

3. Researchers Submit Patent Application, 'Prmt5 Inhibitors', for Approval (USPTO 20210309688)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Women -- Health aspects, B cells, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 OCT 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Lim, [...]

Published
2021

4. Patent Issued for PRMT5 inhibitors (USPTO 11098059)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Women -- Health aspects, B cells -- Reports, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 SEP 16 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Altman, Michael [...]

Published
2021

5. Patent Application Titled 'Recombinant Expression Of Chlamydia Momp Antigen' Published Online (USPTO 20210093703)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Antigens, Amino acids -- Intellectual property, Chlamydia, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2021

6. Researchers Submit Patent Application, 'Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer', for Approval (USPTO 20200325228)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer treatment, Axitinib, Endothelial growth factors, Neovascularization, Cancer, Women's health, Palladium -- Intellectual property, Pembrolizumab, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2020 NOV 5 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Martini, [...]

Published
2020

7. Patent Issued for Combination Of A PD-1 Antagonist And An ALK Inhibitor For Treating Cancer (USPTO 10,695,426)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer treatment -- Reports, Crizotinib -- Reports, Cancer -- Reports, Women's health -- Reports, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2020 JUL 16 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Das-Young, Leena [...]

Published
2020

8. 'Scoring Methods For Anti-Pd Therapy Eligibility And Compositions For Performing Same' in Patent Application Approval Process (USPTO 20200200759)

Subjects
Bristol-Myers Squibb Co. -- Intellectual property, Merck Sharp & Dohme Corp. -- Intellectual property, Women's health -- Methods, Nivolumab -- Methods, Avelumab -- Intellectual property -- Methods, Palladium -- Methods -- Intellectual property, Pembrolizumab -- Methods, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2020 JUL 16 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors Kulangara, Karina (Carpinteria, CA); Zhang, Nancy (Thousand Oaks, [...]

Published
2020

9. Patent Issued for Recombinant Expression Of Chlamydia MOMP Antigen (USPTO 10,675,339)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Antigens, Chlamydia, Amino acids -- Intellectual property, Health, Women's issues/gender studies
Abstract

2020 JUN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Zhang, Lan (Chalfont, PA); Wen, Zhiyun (Devon, PA); Przysiecki, [...]

Published
2020

10. Patent Issued for Combination Of A PD-1 Antagonist And A VEGFR Inhibitor For Treating Cancer (USPTO 10,570,202)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer treatment, Axitinib, Endothelial growth factors, Neovascularization, Cancer, Women's health, Pembrolizumab, Pharmaceutical industry -- Intellectual property, Containers, Editors, Health, Women's issues/gender studies
Abstract

2020 MAR 12 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Martini, Jean-Francois Andre (Carlsbad, CA); Tarazi, Jamal Christo (San [...]

Published
2020

11. 'Treating Cancer With A Combination Of A Pd-1 Antagonist And An Il-27 Antagonist' in Patent Application Approval Process (USPTO 20190270802)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer treatment, Cancer, Women's health, Palladium, Pharmaceutical industry -- Intellectual property, Containers, Anopheles, Editors, Women, Health, Women's issues/gender studies
Abstract

2019 SEP 26 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors Shifrin, Nataliya Tovbis (Redwood City, CA); de Waal [...]

Published
2019

12. 'Recombinant Expression Of Chlamydia Momp Antigen' in Patent Application Approval Process (USPTO 20190046626)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Pharmaceutical industry -- Intellectual property, Antigens, Amino acids, Women's health, Women, Health, Chlamydia, Editors, Health, Women's issues/gender studies
Abstract

2019 MAR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors Zhang, Lan (Chalfont, PA); Wen, Zhiyun (Devon, PA); [...]

Published
2019

13. Researchers Submit Patent Application, 'Novel Substituted Tetrahydroquinolin Compounds As Indoleamine 2,3-Dioxygenase (Ido) Inhibitors', for Approval (USPTO 20220235028)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Vaccines -- Intellectual property, Pharmaceutical industry -- Intellectual property, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2022 AUG 15 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Deng, [...]

Published
2022

14. Patent Issued for Treating Cancer with a Combination of a PD-1 Antagonist and Dinaciclib (USPTO 9827309)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer treatment, Cancer, Women's health, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Health, Women's issues/gender studies
Abstract

2017 DEC 14 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Strack, Peter Richard (Reading, MA); Booher, Robert (Davis, CA); [...]

Published
2017

17. Researchers Submit Patent Application, 'Pharmaceutical Formulation Comprising Incretin-Insulin Conjugates', for Approval (USPTO 20200069809)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Type 2 diabetes, Amino acids, Pharmaceutical industry -- Intellectual property, Insulin, Obesity, Diabetes mellitus, Public health, Editors, Public health movements, Health
Abstract

2020 MAR 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]

Published
2020

18. Patent Application Titled 'Predictive Biomarker Useful for Cancer Therapy Mediated by a Cdk Inhibitor' Published Online

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer treatment, Cancer, Women's health, Patents, Pharmaceutical industry -- Intellectual property, Antineoplastic agents, Patent/copyright issue, Health, Women's issues/gender studies
Abstract

By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors Booher, Robert [...]

Published
2015

19. 'Indole Derivatives Useful As Inhibitors Of Diacylglyceride O-Acyltransferase 2' in Patent Application Approval Process (USPTO 20190276443)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Type 2 diabetes, Pharmaceutical industry -- Intellectual property, Obesity, Editors, Health
Abstract

2019 SEP 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- A patent application by the inventors Shen, Dong-Ming (Edison, NJ); Graham, Thomas H. [...]

Published
2019

20. Patent Issued for Aryl Acylsulfonamides As BLT1 Antagonists (USPTO 10,370,368)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Hypoglycemic agents, Type 2 diabetes, Pharmaceutical industry -- Intellectual property, Dulaglutide, Semaglutide, Liraglutide, Obesity, Saxagliptin, Alogliptin, Diabetes mellitus, Linagliptin, Exenatide, Sitagliptin, Editors, Health
Abstract

2019 AUG 19 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- A patent by the inventors Han, Yongxin (Needham, MA); Tummanapalli, Satyanarayana (Hyderabad, IN); [...]

Published
2019

21. Researchers Submit Patent Application, 'Modulation Of Tumor Immunity', for Approval (USPTO 20180207266)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer vaccines, B cells, Cancer -- Development and progression, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2018 AUG 13 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Vaccine Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Danling, [...]

Published
2018

22. Patent Issued for Ceftolozane-Tazobactam Pharmaceutical Compositions (USPTO 9925196)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Computers
Abstract

2018 APR 10 (VerticalNews) -- By a News Reporter-Staff News Editor at Information Technology Newsweekly -- A patent by the inventors Terracciano, Joseph (Concord, MA); Damour, Nicole Miller (Belmont, MA); [...]

Published
2018

23. Researchers Submit Patent Application, 'Polycyclic Heterocycle Derivatives and Methods of Use Thereof for the Treatment of Viral Diseases', for Approval (USPTO 20160243128)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Patents -- Methods, Hepatitis C virus -- Methods, Pharmaceutical industry -- Intellectual property -- Methods, Patent/copyright issue, Biotechnology industry, Health, Science and technology
Abstract

2016 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]

Published
2016

24. Patent Issued for IL-8 Level as a Determinant of Responsivity of a Cancer to Treatment (USPTO 9229008)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer treatment, Cancer genetics, Cancer, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Biotechnology industry, Health, Science and technology
Abstract

2016 JAN 18 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent [...]

Published
2016

25. Patent Issued for SYN3 Compositions and Methods (USPTO 9115374)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer genetics -- Methods, Gene therapy -- Methods, Patents -- Methods, Pharmaceutical industry -- Intellectual property -- Methods, Biotechnology industry, Health, Science and technology
Abstract

2015 SEP 7 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Ihnat, [...]

Published
2015

26. Patent Issued for Phenyl Carboxamide-Containing Spleen Tyrosine Kinase (SYK) Inhibitors

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, B cells, Patents, Tyrosine, Pharmaceutical industry -- Intellectual property, Phenols (Class of compounds), Patent/copyright issue, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Altman, Michael D. (Needham, MA); Di Francesco, [...]

Published
2015

27. Patent Issued for 3-Pyridyl Carboxamide-Containing Spleen Tyrosine Kinase (SYK) Inhibitors

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, B cells, Patents, Tyrosine, Pharmaceutical industry -- Intellectual property, Phenols (Class of compounds), Patent/copyright issue, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- A patent by the inventors Altman, Michael D. (Needham, MA); Childers, Kaleen Konrad (Newton, MA); Donofrio, Anthony (Cambridge, MA); [...]

Published
2015

29. Prospective Grant of Exclusive License: Prevention, Prophylaxis, Cure, Amelioration, and/or Treatment of Infection and/or the Effects Thereof of Chikungunya Infections in Humans

Subjects
United States. National Institutes of Health, Merck Sharp & Dohme Corp. -- Intellectual property, Government
Abstract

SUMMARY: This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the [...]

Published
2010

30. Patent Issued for Uses of Mammalian Cytokines and Agonists; Related Reagents

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cytokines, Tumors, Vaccines, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

By a News Reporter-Staff News Editor at Cancer Vaccine Week -- Merck, Sharp & Dohme Corp. (Rahway, NJ) has been issued patent number 8822405, according to news reporting originating out [...]

Published
2014

31. Patent Issued for IL-8 Biomarker for Monitoring Cancer Treatment with Certain ERK Inhibitors

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Tumors, Phosphotransferases, Cancer -- Care and treatment -- Genetic aspects, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Biotechnology industry, Health, Science and technology
Abstract

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Samatar, Ahmed A. (West Windsor, NJ); [...]

Published
2013

32. Researchers Submit Patent Application, 'Polycyclic Heterocycle Derivatives and Methods of Use Thereof for the Treatment of Viral Diseases', for Approval

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Patents -- Methods, Pharmaceutical industry -- Intellectual property -- Methods, Virus diseases -- Methods, Patent/copyright issue, Biotechnology industry, Health, Science and technology
Abstract

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Vacca, Joseph P. (Telford, PA); [...]

Published
2013

33. Patent Issued for Methods to Treat And/Or Prevent Mucositis

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer -- Genetic aspects, Patents -- Methods, Pharmaceutical industry -- Intellectual property -- Methods, Patent/copyright issue, Biotechnology industry, Health, Science and technology
Abstract

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- A patent by the inventor Zong, Chen (Metuchen, NJ), filed on February 8, 2008, was published online on [...]

Published
2013

34. Patent Issued for Self-Emulsifying Formulations of CETP Inhibitors

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cholesterol, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Sheth, Agam R. [...]

Published
2013

35. Patent Issued for Combination Cancer Therapy with an AKT Inhibitor and Other Anticancer Agents

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Antineoplastic agents, Antibacterial agents, Cancer -- Care and treatment, Patents, Pharmaceutical industry -- Intellectual property, Antimitotic agents, Patent/copyright issue, Biotechnology industry, Health, Science and technology
Abstract

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- A patent by the inventors Layton, Mark E. (Harleysville, PA); Hirai, Hiroshi (Tsukuba, JP); Kotani, Hidehito (Tsukuba, JP), [...]

Published
2013

36. Patent Issued for Prodrugs of Oxazolidinone CETP Inhibitors

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cholesterol, Cardiovascular diseases, Patents, Pharmaceutical industry -- Intellectual property, Atherosclerosis, Patent/copyright issue, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Mills, Sander G. (Scotch Plains, NJ); Ali, [...]

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results